A model for gene evolution of the ets-1/ets-2 transcription factors based on structural and functional homologies.

Abstract:

:The chicken c-ets-1 locus encodes two transcription factors, p54c-ets-1 and p68c-ets-1 that differ in their N-termini, encoded respectively by the I54 and alpha beta exons. p68c-ets-1 equivalents are only found in birds and reptiles while p54c-ets-1 is widely conserved in vertebrates, from amphibians to mammals. Thus, the classical view concerning the evolution of the c-ets-1 gene has been to consider that I54 is of ancient origin whereas alpha and beta, which provide an additional activating domain in p68c-ets-1, would have been acquired much more recently. Sequencing the alpha and beta exons in various species pinpointed a highly conserved region of 13 amino acids which is rich in acidic and hydrophobic residues, a feature of some other transactivating domains. Strikingly, this subdomain is also present in the otherwise unrelated N-terminal activating region of p58c-ets-2 and was thus named BEC for Ets-1-beta/Ets-2-Conserved sequence. Moreover, the two N-termini share the BEC sequence at a homologous position in their highly similar genomic organization indicating a common origin. This structural homology underlies a functional similarity since fusion of the heterologous GAL4 DNA-binding domain with either of the two isolated domains demonstrates that BEC is essential in both cases for the transactivating activity. The function of the alpha beta domain in the context of p68c-ets-1 also strictly depends on the presence of the BEC sequence. Finally, the whole N-terminus of p58c-ets-2 can functionally substitute for its counterpart in p68c-ets-1 further demonstrating that p68c-ets-1 and p58c-ets-2 are structurally and functionally more closely related than previously thought. Besides, we also found BEC in the N-terminus of the Drosophila pointed gene which may be considered as closely related to the uncommitted 'ets1/2' common ancestor. These data demonstrate that the alpha and beta exons are not a recent and specific acquisition but stem, like the p58c-ets-2 N-terminus, from the invertebrate unduplicated 'ets 1/2' gene. This work unravels a new model for the ets-1/ets-2 gene's evolution, based for the first time on both structural and functional evidences. Accordingly, p68c-ets-1 and p58c-ets-2 are the direct descendants of the ancestral 'ets1/2' gene whereas I54 may have been acquired as a second promoter in the c-ets-1 gene after the duplication. Indeed, I54 is not found in the Drosophila pointed gene. The high degree of similarity, and hence of functional redundancy, between p68c-ets-1 and p58c-ets-2 may have led to the rapid divergence (and even loss in mammals) of alpha and beta during evolution whereas I54, which provided a novel function unique to c-ets-1, was maintained within the presently widespread p54c-ets-1 version.

journal_name

Oncogene

journal_title

Oncogene

authors

Albagli O,Soudant N,Ferreira E,Dhordain P,Dewitte F,Begue A,Flourens A,Stehelin D,Leprince D

subject

Has Abstract

pub_date

1994-11-01 00:00:00

pages

3259-71

issue

11

eissn

0950-9232

issn

1476-5594

journal_volume

9

pub_type

杂志文章

相关文献

ONCOGENE文献大全
  • Interactions between wild-type and mutant Ras genes in lung and skin carcinogenesis.

    abstract::Ras oncogenes (Hras, Kras and Nras) are important drivers of carcinogenesis. However, tumors with Ras mutations often show loss of the corresponding wild-type (WT) allele, suggesting that proto-oncogenic forms of Ras can function as a suppressor of carcinogenesis. In vitro studies also suggest that WT Ras proteins can...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2012.404

    authors: To MD,Rosario RD,Westcott PM,Banta KL,Balmain A

    更新日期:2013-08-22 00:00:00

  • Loss of Mel-18 induces tumor angiogenesis through enhancing the activity and expression of HIF-1α mediated by the PTEN/PI3K/Akt pathway.

    abstract::Mel-18 has been implicated in several processes in tumor progression, in which the Akt pathway is involved as an important key molecular event. However, the function of Mel-18 in human cancers has not been fully established yet. Here, we examined the effect of Mel-18 on tumor angiogenesis in human breast cancer, and f...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2011.174

    authors: Park JH,Lee JY,Shin DH,Jang KS,Kim HJ,Kong G

    更新日期:2011-11-10 00:00:00

  • Future prospects for oncolytic therapy.

    abstract::Viruses have been engineered to replicate selectively in cancer cells, based on a number of innovative principles. Several of these viruses have entered clinical trials and have proven relatively safe, and have shown evidence of efficacy. However, further research is required to enable these agents to function systemi...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1209064

    authors: McCormick F

    更新日期:2005-11-21 00:00:00

  • Interferon-induces expression of cyclin-dependent kinase-inhibitors p21WAF1 and p27Kip1 that prevent activation of cyclin-dependent kinase by CDK-activating kinase (CAK).

    abstract::To understand the mechanism of interferon (IFN)-mediated suppression of cell cycle progression, we have earlier shown that IFN-alpha enhances the expression of underphosphorylated retinoblastoma protein by inhibiting the cyclin-dependent kinase-2 (CDK-2) activity (Kumar and Atlas, Proc. Natl. Acad. Sci. 89, 6599-6603,...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1201529

    authors: Mandal M,Bandyopadhyay D,Goepfert TM,Kumar R

    更新日期:1998-01-15 00:00:00

  • Nrf2 and Nrf1 in association with Jun proteins regulate antioxidant response element-mediated expression and coordinated induction of genes encoding detoxifying enzymes.

    abstract::Antioxidant response element (ARE)-mediated expression and coordinated induction of genes encoding detoxifying enzymes is one mechanism of critical importance to cellular protection against oxidative stress. In the present report, we demonstrate that nuclear transcription factors Nrf2 and Nrf1 associate with Jun (c-Ju...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1202237

    authors: Venugopal R,Jaiswal AK

    更新日期:1998-12-17 00:00:00

  • MUC1-C activates BMI1 in human cancer cells.

    abstract::B-cell-specific Moloney murine leukemia virus integration site 1 (BMI1) is a component of the polycomb repressive complex 1 (PRC1) complex that is overexpressed in breast and other cancers, and promotes self-renewal of cancer stem-like cells. The oncogenic mucin 1 (MUC1) C-terminal (MUC1-C) subunit is similarly overex...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2016.439

    authors: Hiraki M,Maeda T,Bouillez A,Alam M,Tagde A,Hinohara K,Suzuki Y,Markert T,Miyo M,Komura K,Ahmad R,Rajabi H,Kufe D

    更新日期:2017-05-18 00:00:00

  • Characterization of a major colon cancer susceptibility locus (Ccs3) on mouse chromosome 3.

    abstract::Treatment of mice with the carcinogen azoxymethane (AOM) induces a number of lesions in the colon, including hyperplastic lesions, as well adenomas and carcinomas in situ. Inbred strains of mice show different responses to AOM-induced carcinogenesis. A/J mice are highly susceptible and develop a greater number of hype...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2009.369

    authors: Meunier C,Cai J,Fortin A,Kwan T,Marquis JF,Turbide C,Van Der Kraak L,Jothy S,Beauchemin N,Gros P

    更新日期:2010-02-04 00:00:00

  • Cloning and sequencing of the human c-abl 3' untranslated region.

    abstract::The human c-abl oncogene gives rise to different mRNA transcripts which vary primarily in that they possess alternative first exons. In the present study, we present the sequence for the human c-abl 3' untranslated region (3'utr) and show that while human and murine c-abl cDNA sequences are generally homologous, human...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Andrews DF 3rd,Tompkins CK,Hendrickson SL,Singer JW

    更新日期:1990-03-01 00:00:00

  • MKP1/CL100 controls tumor growth and sensitivity to cisplatin in non-small-cell lung cancer.

    abstract::Non-small-cell lung cancer (NSCLC) represents the most frequent and therapy-refractive sub-class of lung cancer. Improving apoptosis induction in NSCLC represents a logical way forward in treating this tumor. Cisplatin, a commonly used therapeutic agent in NSCLC, induces activation of N-terminal-c-Jun kinase (JNK) tha...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1209364

    authors: Chattopadhyay S,Machado-Pinilla R,Manguan-García C,Belda-Iniesta C,Moratilla C,Cejas P,Fresno-Vara JA,de Castro-Carpeño J,Casado E,Nistal M,Gonzalez-Barón M,Perona R

    更新日期:2006-06-01 00:00:00

  • Identifying targets for the restoration and reactivation of BRM.

    abstract::Brahma (BRM) is a novel anticancer gene, which is frequently inactivated in a variety of tumor types. Unlike many anticancer genes, BRM is not mutated, but rather epigenetically silenced. In addition, histone deacetylase complex (HDAC) inhibitors are known to reverse BRM silencing, but they also inactivate it via acet...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2012.613

    authors: Kahali B,Gramling SJ,Marquez SB,Thompson K,Lu L,Reisman D

    更新日期:2014-01-30 00:00:00

  • Characterization of ret proto-oncogene mRNAs encoding two isoforms of the protein product in a human neuroblastoma cell line.

    abstract::The ret proto-oncogene expresses four major mRNA species of different lengths in human malignant cell lines and rat tissues. We isolated ret proto-oncogene cDNA clones from a cDNA library of a human neuroblastoma line, Nagai, which over-expressed these mRNAs. Four cDNA clones differing from each other in their 3' port...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Tahira T,Ishizaka Y,Itoh F,Sugimura T,Nagao M

    更新日期:1990-01-01 00:00:00

  • The Tek/Tie2 receptor signals through a novel Dok-related docking protein, Dok-R.

    abstract::Tek/Tie2 is an endothelial cell-specific receptor tyrosine kinase that has been shown to play a role in vascular development of the mouse. Targeted mutagenesis of both Tek and its agonistic ligand, Angiopoietin-1, result in embryonic lethality, demonstrating that the signal transduction pathway(s) mediated by this rec...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1202115

    authors: Jones N,Dumont DJ

    更新日期:1998-09-03 00:00:00

  • Localization of chromosome 8p regions involved in early tumorigenesis of oral and laryngeal squamous carcinoma.

    abstract::We analysed 30 primary invasive oral and laryngeal squamous carcinomas (SC), with concurrent dysplastic lesions, for genetic alterations at 15 microsatellite loci on the short arm of chromosome 8. Overall, loss of heterozygosity (LOH) was observed, in at least one informative locus, in 27% of the dysplastic lesions an...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1201808

    authors: El-Naggar AK,Coombes MM,Batsakis JG,Hong WK,Goepfert H,Kagan J

    更新日期:1998-06-11 00:00:00

  • Retinoic acid and arsenic trioxide cooperate for apoptosis through phosphorylated RXR alpha.

    abstract::Arsenite trioxide (As2O3) induces apoptosis in several cell lines by disturbing key signal transduction pathways through its oxidative properties. Here, we report that As2O3 also induces the phosphorylation of the retinoid receptor RXRalpha, subsequent to oxidative damages and the activation of the stress-activated pr...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1208402

    authors: Tarrade A,Bastien J,Bruck N,Bauer A,Gianni M,Rochette-Egly C

    更新日期:2005-03-31 00:00:00

  • Extramammary Paget's disease patient-derived xenografts harboring ERBB2 S310F mutation show sensitivity to HER2-targeted therapies.

    abstract::Although the prognosis of advanced extramammary Paget's disease (EMPD) is poor, there have been no preclinical research models for the development of novel therapeutics. This study aims to establish a preclinical research model for EMPD. We transplanted EMPD tissue into immunodeficient NOD/Scid mice. Histopathological...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-020-01404-x

    authors: Maeda T,Kitamura S,Nishihara H,Yanagi T

    更新日期:2020-09-01 00:00:00

  • AP-1 complexes containing cJun and JunB cause cellular transformation of Rat1a fibroblasts and share transcriptional targets.

    abstract::To investigate the role of individual Jun proteins in cell growth and transformation, we have used a doxycycline-inducible retroviral vector to regulate their expression in rat fibroblasts. AP-1 complexes enriched with cJun and JunB result in morphological alterations and anchorage-independent cell growth consistent w...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1206644

    authors: Leaner VD,Kinoshita I,Birrer MJ

    更新日期:2003-08-28 00:00:00

  • Structural and functional involvement of p53 in BER in vitro and in vivo.

    abstract::p53 is involved in several DNA repair pathways. Some of these require the specific transactivation of p53-dependent genes and others involve direct interactions between the p53 protein and DNA repair associated proteins. Previously, we have shown that p53 acts directly in Base Excision Repair (BER) when assayed under ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1204120

    authors: Offer H,Milyavsky M,Erez N,Matas D,Zurer I,Harris CC,Rotter V

    更新日期:2001-02-01 00:00:00

  • Transactivation of the p21 promoter by BRCA1 splice variants in mammary epithelial cells: evidence for both common and distinct activities of wildtype and mutant forms.

    abstract::We have evaluated the transcriptional activation of a human p21 promoter reporter construct by transfection of BRCA1 expression constructs into tumorigenic and nontumorigenic human breast cell lines. Two cell lines with wildtype p53 (MCF-7 and MCF10A) demonstrated transcriptional activation of the p21 promoter by full...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1204025

    authors: Lu M,Arrick BA

    更新日期:2000-12-14 00:00:00

  • v-Myb represses the transcription of Ets-2.

    abstract::The v-Myb oncogene causes monoblastic leukemia and transforms only myelomonocytic cells in culture. The v-Myb protein is nuclear and binds to specific DNA sequences. To identify genes regulated by v-Myb, we utilized primary cells transformed by a retrovirus encoding a v-Myb-estrogen receptor (ER) fusion protein. The E...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1209868

    authors: Wang DM,Sevcikova S,Wen H,Roberts S,Lipsick JS

    更新日期:2007-02-22 00:00:00

  • WEE1 accumulation and deregulation of S-phase proteins mediate MLN4924 potent inhibitory effect on Ewing sarcoma cells.

    abstract::Ewing sarcoma (ES) is an aggressive bone and soft tissue tumor of children and young adults in which finding effective new targeted therapies is imperative. Here, we report an in-depth preclinical study of the investigational cullin-RING ubiquitin ligase (CRL) inhibitor MLN4924 in ES, as we have recently demonstrated ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2012.153

    authors: Mackintosh C,García-Domínguez DJ,Ordóñez JL,Ginel-Picardo A,Smith PG,Sacristán MP,de Álava E

    更新日期:2013-03-14 00:00:00

  • Cyclooxygenase-2 (COX-2) inhibitors sensitize tumor cells specifically to death receptor-induced apoptosis independently of COX-2 inhibition.

    abstract::Cyclooxygenase-2 (COX-2) is involved in diverse processes such as inflammation, carcinogenesis and apoptosis. As COX-2 inhibitors interfere with these processes, inhibition of COX-2 has been suggested as a promising anticancer treatment. However, the role of COX-2 in modulation of apoptosis as well as the death pathwa...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1206837

    authors: Totzke G,Schulze-Osthoff K,Jänicke RU

    更新日期:2003-09-11 00:00:00

  • Tumor stroma: a complexity dictated by the hypoxic tumor microenvironment.

    abstract::A lot of effort has been done to study how cancer cells react to low-oxygen tension, a condition known as hypoxia. Indeed, abnormal and dysfunctional blood vessels in the tumor are incapable to restore oxygenation, therefore perpetuating hypoxia, which, in turn, will fuel tumor progression, metastasis and resistance t...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/onc.2013.121

    authors: Casazza A,Di Conza G,Wenes M,Finisguerra V,Deschoemaeker S,Mazzone M

    更新日期:2014-04-03 00:00:00

  • Critical appraisal of the use of matrix metalloproteinase inhibitors in cancer treatment.

    abstract::Experimental studies performed prior to 1990 led to the widely held belief that matrix metalloproteinases (MMPs) produced by cancer cells are of critical importance in tumor invasion and metastasis. Based on this evidence, the pharmaceutical industry produced several well tolerated, orally active MMP inhibitors (MMPIs...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/sj.onc.1204097

    authors: Zucker S,Cao J,Chen WT

    更新日期:2000-12-27 00:00:00

  • Cdc25B activity is regulated by 14-3-3.

    abstract::In the G2 phase cell cycle checkpoint arrest, the cdc25-dependent activation of cyclin B/cdc2, a critical step in regulating entry into mitosis, is blocked. Studies in yeast have demonstrated that the inhibition of cdc25 function involves 14-3-3 binding to cdc25. In humans, two cdc25 isoforms have roles in G2/M progre...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1204574

    authors: Forrest A,Gabrielli B

    更新日期:2001-07-19 00:00:00

  • Inhibition of oxidative phosphorylation underlies the antiproliferative and proapoptotic effects of mofarotene (Ro 40-8757) in Burkitt's lymphoma cells.

    abstract::In the search for retinoids active against Burkitt's lymphoma (BL), we found that the arotinoid mofarotene (Ro 40-8757) induced strong antiproliferative and apoptotic responses in most established BL cell lines as well as in primary BL cells. Ro 40-8757-induced apoptosis is associated with mitochondrial membrane depol...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1206060

    authors: Cariati R,Zancai P,Righetti E,Rizzo S,De Rossi A,Boiocchi M,Dolcetti R

    更新日期:2003-02-13 00:00:00

  • MET targeting: time for a rematch.

    abstract::MET, the receptor tyrosine kinase (RTK) for hepatocyte growth factor, is a proto-oncogene involved in embryonic development and throughout life in homeostasis and tissue regeneration. Deregulation of MET signaling has been reported in numerous malignancies, prompting great interest in MET targeting for cancer therapy....

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/s41388-020-1193-8

    authors: Koch JP,Aebersold DM,Zimmer Y,Medová M

    更新日期:2020-04-01 00:00:00

  • Human INT6 interacts with MCM7 and regulates its stability during S phase of the cell cycle.

    abstract::The mouse int6 gene is a frequent integration site of the mouse mammary tumor virus and INT6 silencing by RNA interference in HeLa cells causes an increased number of cells in the G2/M phases of the cell cycle, along with mitotic defects. In this report, we investigated the functional significance of the interaction b...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1210314

    authors: Buchsbaum S,Morris C,Bochard V,Jalinot P

    更新日期:2007-08-02 00:00:00

  • Novel synthetic bisindolylmaleimide alkaloids inhibit STAT3 activation by binding to the SH2 domain and suppress breast xenograft tumor growth.

    abstract::Signal transducer and activator of transcription 3 (STAT3) is constitutively activated in malignant tumors and plays important roles in multiple aspects of cancer aggressiveness. Thus, targeting STAT3 promises to be an attractive strategy for the treatment of advanced metastatic tumors. Bisindolylmaleimide alkaloid (B...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-017-0076-0

    authors: Li X,Ma H,Li L,Chen Y,Sun X,Dong Z,Liu JY,Zhu W,Zhang JT

    更新日期:2018-05-01 00:00:00

  • BRCA1 proteins are transported to the nucleus in the absence of serum and splice variants BRCA1a, BRCA1b are tyrosine phosphoproteins that associate with E2F, cyclins and cyclin dependent kinases.

    abstract::BRCA1, a familial breast and ovarian cancer susceptibility gene encodes nuclear phosphoproteins that function as tumor suppressors in human breast cancer cells. Previously, we have shown that overexpression of a BRCA1 splice variant BRCA1a accelerates apoptosis in human breast cancer cells. In an attempt to determine ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1201252

    authors: Wang H,Shao N,Ding QM,Cui J,Reddy ES,Rao VN

    更新日期:1997-07-10 00:00:00

  • Oncogenic miR-20a and miR-106a enhance the invasiveness of human glioma stem cells by directly targeting TIMP-2.

    abstract::Emerging evidence has shown that cancer stem cells (CSCs) are the cellular determinants to promote cancer invasion and metastasis. However, the mechanism underlying CSC invasion remains unknown. MicroRNAs are evolutionally conserved small noncoding RNAs that are critical for the regulation of gene expression, and thei...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2014.75

    authors: Wang Z,Wang B,Shi Y,Xu C,Xiao HL,Ma LN,Xu SL,Yang L,Wang QL,Dang WQ,Cui W,Yu SC,Ping YF,Cui YH,Kung HF,Qian C,Zhang X,Bian XW

    更新日期:2015-03-12 00:00:00